Associate Professor Paul Cameron from the Department of Infectious Diseases has co-authored a paper in Nature Communications describing a novel method to track the
effects of influenza vaccination, cancer, infectious diseases and immune diseases on the diversity and repertoire of disease-fighting immune cells within an individual. The method combines state-of-the-art next generation sequencing and online analytical databases. Reference: "IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next
generation repertoire immunoprofiling" (http://www.ncbi.nlm.nih.gov/
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.